Pulmonx (LUNG) Total Debt (2019 - 2025)

Pulmonx (LUNG) has reported Total Debt for 7 consecutive years, with $37.2 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Total Debt fell 7.81% year-over-year to $37.2 million in Q4 2025; TTM through Dec 2025 was $37.2 million, a 7.81% decrease from a year earlier, with the FY2025 full-year figure at $37.2 million, down 7.81% from the prior year.
• Total Debt was $37.2 million for Q4 2025 at Pulmonx, roughly flat from $37.3 million in the prior quarter.
• Over five years, Total Debt peaked at $52.8 million in Q1 2025 and troughed at $17.4 million in Q4 2022.
• A 5-year average of $34.3 million and a median of $37.3 million in 2025 frame the typical range for Total Debt.
• Across the five-year window, Total Debt tumbled 44.27% in 2022 and surged 126.25% in 2023, its largest moves.
• Over 5 years, Total Debt stood at $17.6 million in 2021, then declined by 1.02% to $17.4 million in 2022, then surged by 126.25% to $39.4 million in 2023, then grew by 2.42% to $40.4 million in 2024, then fell by 7.81% to $37.2 million in 2025.
• The last three Total Debt figures came in at $37.2 million (Q4 2025), $37.3 million (Q3 2025), and $37.3 million (Q2 2025), per Business Quant data.